Confirmed keynote presenters: Suga Hiroaki, Univ. of Tokyo; Naheed Kurji, Recursion Canada. Other confirmed presenters include: Veronica Ajewole, Texas Southern Univ.; Rodabe Amaria, MD Anderson Cancer Center; Jason Bock, CTMC+; Kate Broderick, Maravai LifeSciences; José Duca, Novartis; Mohamed ElSayed, RVAC Medicines; Jimmy Gollihar, Houston Methodist Research Institute; Rosalia Guerrero, Univ. of Texas School of Public Health; Alexander Kabanov, Univ. of North Carolina, Chapel Hill; Elaine Lea-Chou, ELC Private Consulting; Jing Li, Rice Univ.; Charlene Liao, Immune-Onc Therapeutics; Qingyun (Jim) Liu, UTHealth; Michael Mitchell, Univ. of Pennsylvania; Amanda Onwuka, RTI International; Kevin Slawin, Ponce Therapeutics and Deliver Therapeutics, Inc.; Xiaotong Song, Texas A&M Univ. Institute of Biosciences & Technology; Cassian Yee, MD Anderson Cancer Center; Chengcheng (Alec) Zhang, Univ. of Texas Southwestern Medical Center; and Hong Zhao, FDA